Source: Health Products Regulatory Authority (ZA) Revision Year: 2024 Publisher: Austell Pharmaceuticals (Pty) Ltd, 1 Sherborne Road, Parktown, Johannesburg, 2193, Tel: +27 11 611 1400 or +27 860 287 835
ZELARY 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablets. ZELARY 10 mg tablets: White, circular biconvex film-coated tablets with a score line on one side. The tablet can be divided into equal halves. |
Each film-coated tablet contains 10 mg cetirizine dihydrochloride.
Contains sugar: lactose monohydrate 105 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors. |
| List of Excipients |
|---|
|
Tablet core: Maize starch Tablet coat: Hypromellose (Hydroxypropyl methylcellulose) |
ZELARY 10 tablets are packed in PVC/PVDC Aluminium Blister.
The tablets are packed in blisters of 10’s.
The pack sizes are 1 × 10 and 3 × 10’s in a unit carton.
Not all pack sizes may be marketed.
Austell Pharmaceuticals (Pty) Ltd, 1 Sherborne Road, Parktown, Johannesburg, 2193, Tel: +27 11 611 1400 or +27 860 287 835
37/5.7.1/0428
02 July 2004
| Drug | Countries | |
|---|---|---|
| ZELARY | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.